Sold strictly for research and analytical purposes only
Because it targets GLP-1, GIP, and glucagon pathways, side effects and monitoring needs may be more complex than single-pathway medications
GLP-1 receptor agonists have been effectively used in clinical trials for the treatment of T2DM, and various GLP-1-based pharmacotherapies are now being evaluated in clinical trials for the treatment of obesity [19]
High-quality protein sources include: Lean poultry (chicken, turkey) Fish and seafood (salmon, cod, shrimp) Eggs and egg whites Greek yogurt and cottage cheese Legumes (lentils, chickpeas, black beans) Lean cuts of beef and pork Note: Individuals with chronic kidney disease should consult their healthcare provider before significantly increasing protein intake
It does not identify obesity or metabolic disease
Currently, there is only one drug in this class of medicationstirzepatide, which is approved as Mounjaro for treatment of Type 2 diabetes and as Zepbound for the treatment of obesity
